![]() Global Epilepsy Therapeutics Market With Impact Analysis of US Tariffs (2025 Edition)
Executive Summary Azoth Analytics has released a research report titled “Global Epilepsy Therapeutics Market (2025 Edition)” which provides an analysis of the Global Epilepsy Therapeutics indust... もっと見る
SummaryExecutive SummaryAzoth Analytics has released a research report titled “Global Epilepsy Therapeutics Market (2025 Edition)” which provides an analysis of the Global Epilepsy Therapeutics industry in terms of market segmentation By Generation (First Generation, Second Generation, Third Generation), By Route of Administration (Oral, Intravenous), By Type (Branded, Generics). The report analyses the Epilepsy Therapeutics Market by Region (Americas, Europe, Asia Pacific, Middle East & Africa) and 10 Countries (United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India). The epilepsy therapeutics market is projected to experience sustained growth over the coming years, driven by increasing epilepsy prevalence, rising awareness, advancements in drug development, and greater access to healthcare across both developed and emerging markets. Increasing diagnosis rates, greater awareness, and improved access to healthcare are contributing to rising epilepsy prevalence worldwide. Aging populations and the higher incidence of epilepsy in both the very young and elderly are further driving demand for effective therapeutics. The global burden of epilepsy, affecting over 50 million people, continues to drive demand. Regions with increasing awareness and healthcare access, such as Latin America, are particularly contributing to growth as epilepsy is highly prevalent, especially in children. High demand for paediatric epilepsy care has been observed due to rising incidence rates and population growth. There is a focus on making Anti-Epileptic Drugs more accessible in this region as awareness and diagnosis rates improve. Table of ContentsTable of Content1. Market Background 1.1 Scope and Product Outlook 1.2 Executive Summary 1.3 Research Methodology 2. Analyst Recommendations 2.1 Innovation in Drug Formulation 2.2 Telemedicine and Digital Health 3. Epilepsy Therapeutics Market: Historic and Forecast 3.1 Impact Analysis of Macro Economic Factors on Epilepsy Therapeutics Market 3.2 Global Prevalence of Infectious Disease, 2019 3.3 Global Incidence of Infectious Disease, 2019 3.4 Major Epilepsy Drugs in Pipeline, 2024 3.5 Global Epilepsy Therapeutics Market: Dashboard 3.6 Global Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR) 3.7 Global Epilepsy Therapeutics Market: Market Value Assessment 3.8 Global Epilepsy Therapeutics Market Segmentation: By Generation 3.8.1 Global Epilepsy Therapeutics Market, By Generation Overview 3.8.2 Global Epilepsy Therapeutics Market Attractiveness Index, By Generation 3.8.3 Global Epilepsy Therapeutics Market Size, By First Generation, By Value, 2020H-2030F (USD Million & CAGR) 3.8.4 Global Epilepsy Therapeutics Market Size, By Second Generation, By Value, 2020H-2030F (USD Million & CAGR) 3.8.5 Global Epilepsy Therapeutics Market Size, By Third Generation, By Value, 2020H-2030F (USD Million & CAGR) 3.9 Global Epilepsy Therapeutics Market Segmentation: By Route of Administration 3.9.1 Global Epilepsy Therapeutics Market, By Route of Administration Overview 3.9.2 Global Epilepsy Therapeutics Market Attractiveness Index, By Route of Administration 3.9.3 Global Epilepsy Therapeutics Market Size, By Oral, By Value, 2020H-2030F (USD Million & CAGR) 3.9.4 Global Epilepsy Therapeutics Market Size, By Intravenous, By Value, 2020H-2030F (USD Million & CAGR) 3.10 Global Epilepsy Therapeutics Market Segmentation: By Type 3.10.1 Global Epilepsy Therapeutics Market, By Type Overview 3.10.2 Global Epilepsy Therapeutics Market Attractiveness Index, By Type 3.10.3 Global Epilepsy Therapeutics Market Size, By Branded, By Value, 2020H-2030F (USD Million & CAGR) 3.10.4 Global Epilepsy Therapeutics Market Size, By Generics, By Value, 2020H-2030F (USD Million & CAGR) 4. Epilepsy Therapeutics Market, Region Analysis 4.1 Regional Coverage of the Study 4.2 Regional Snapshot 5. Americas Epilepsy Therapeutics Market: Historic and Forecast 5.1 Americas Epilepsy Therapeutics Market: Snapshot 5.2 Americas Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR) 5.3 Americas Epilepsy Therapeutics Market: Key Factors 5.4 Americas Epilepsy Therapeutics Market: Segment Analysis 5.5 Americas Epilepsy Therapeutics Market Segmentation: By Generation 5.5.1 Americas Epilepsy Therapeutics Market, By Generation Overview 5.5.2 Americas Epilepsy Therapeutics Market Size, By First Generation, By Value, 2020H-2030F (USD Million & CAGR) 5.5.3 Americas Epilepsy Therapeutics Market Size, By Second Generation, By Value, 2020H-2030F (USD Million & CAGR) 5.5.4 Americas Epilepsy Therapeutics Market Size, By Third Generation, By Value, 2020H-2030F (USD Million & CAGR) 5.6 Americas Epilepsy Therapeutics Market Segmentation: By Route of Administration 5.6.1 Americas Epilepsy Therapeutics Market, By Route of Administration Overview 5.6.2 Americas Epilepsy Therapeutics Market Size, By Oral, By Value, 2020H-2030F (USD Million & CAGR) 5.6.3 Americas Epilepsy Therapeutics Market Size, By Intravenous, By Value, 2020H-2030F (USD Million & CAGR) 5.7 Americas Epilepsy Therapeutics Market Segmentation: By Type 5.7.1 Americas Epilepsy Therapeutics Market, By Type Overview 5.7.2 Americas Epilepsy Therapeutics Market Size, By Branded, By Value, 2020H-2030F (USD Million & CAGR) 5.7.3 Americas Epilepsy Therapeutics Market Size, By Generics, By Value, 2020H-2030F (USD Million & CAGR) 5.8 Americas Epilepsy Therapeutics Market Segmentation: By Country 5.8.1 Americas Epilepsy Therapeutics Market, by Country Overview 5.8.2 United States Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR) 5.8.2.1 United States Epilepsy Therapeutics Market, By Generation 5.8.2.2 United States Epilepsy Therapeutics Market, By Route of Administration 5.8.2.3 United States Epilepsy Therapeutics Market, By Type 5.8.3 Canada Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR) 5.8.3.1 Canada Epilepsy Therapeutics Market, By Generation 5.8.3.2 Canada Epilepsy Therapeutics Market, By Route of Administration 5.8.3.3 Canada Epilepsy Therapeutics Market, By Type 5.8.4 Rest of Americas Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR) 5.8.4.1 Rest of Americas Epilepsy Therapeutics Market, By Generation 5.8.4.2 Rest of Americas Epilepsy Therapeutics Market, By Route of Administration 5.8.4.3 Rest of Americas Epilepsy Therapeutics Market, By Type 6. Europe Epilepsy Therapeutics Market: Historic and Forecast 6.1 Europe Epilepsy Therapeutics Market: Snapshot 6.2 Europe Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR) 6.3 Europe Epilepsy Therapeutics Market: Key Factors 6.4 Europe Epilepsy Therapeutics Market: Segment Analysis 6.5 Europe Epilepsy Therapeutics Market Segmentation: By Generation 6.5.1 Europe Epilepsy Therapeutics Market, By Generation Overview 6.5.2 Europe Epilepsy Therapeutics Market Size, By First Generation, By Value, 2020H-2030F (USD Million & CAGR) 6.5.3 Europe Epilepsy Therapeutics Market Size, By Second Generation, By Value, 2020H-2030F (USD Million & CAGR) 6.5.4 Europe Epilepsy Therapeutics Market Size, By Third Generation, By Value, 2020H-2030F (USD Million & CAGR) 6.6 Europe Epilepsy Therapeutics Market Segmentation: By Route of Administration 6.6.1 Europe Epilepsy Therapeutics Market, By Route of Administration Overview 6.6.2 Europe Epilepsy Therapeutics Market Size, By Oral, By Value, 2020H-2030F (USD Million & CAGR) 6.6.3 Europe Epilepsy Therapeutics Market Size, By Intravenous, By Value, 2020H-2030F (USD Million & CAGR) 6.7 Europe Epilepsy Therapeutics Market Segmentation: By Type 6.7.1 Europe Epilepsy Therapeutics Market, By Type Overview 6.7.2 Europe Epilepsy Therapeutics Market Size, By Branded, By Value, 2020H-2030F (USD Million & CAGR) 6.7.3 Europe Epilepsy Therapeutics Market Size, By Generics, By Value, 2020H-2030F (USD Million & CAGR) 6.8 Europe Epilepsy Therapeutics Market Segmentation: By Country 6.8.1 Europe Epilepsy Therapeutics Market, by Country Overview 6.8.2 Germany Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR) 6.8.2.1 Germany Epilepsy Therapeutics Market, By Generation 6.8.2.2 Germany Epilepsy Therapeutics Market, By Route of Administration 6.8.2.3 Germany Epilepsy Therapeutics Market, By Type 6.8.3 United Kingdom Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR) 6.8.3.1 United Kingdom Epilepsy Therapeutics Market, By Generation 6.8.3.2 United Kingdom Epilepsy Therapeutics Market, By Route of Administration 6.8.3.3 United Kingdom Epilepsy Therapeutics Market, By Type 6.8.4 France Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR) 6.8.4.1 France Epilepsy Therapeutics Market, By Generation 6.8.4.2 France Epilepsy Therapeutics Market, By Route of Administration 6.8.4.3 France Epilepsy Therapeutics Market, By Type 6.8.5 Italy Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR) 6.8.5.1 Italy Epilepsy Therapeutics Market, By Generation 6.8.5.2 Italy Epilepsy Therapeutics Market, By Route of Administration 6.8.5.3 Italy Epilepsy Therapeutics Market, By Type 6.8.6 Spain Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR) 6.8.6.1 Spain Epilepsy Therapeutics Market, By Generation 6.8.6.2 Spain Epilepsy Therapeutics Market, By Route of Administration 6.8.6.3 Spain Epilepsy Therapeutics Market, By Type 6.8.7 Rest of Europe Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR) 6.8.7.1 Rest of Europe Epilepsy Therapeutics Market, By Generation 6.8.7.2 Rest of Europe Epilepsy Therapeutics Market, By Route of Administration 6.8.7.3 Rest of Europe Epilepsy Therapeutics Market, By Type 7. Asia Pacific Epilepsy Therapeutics Market: Historic and Forecast 7.1 Asia Pacific Epilepsy Therapeutics Market: Snapshot 7.2 Asia Pacific Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR) 7.3 Asia Pacific Epilepsy Therapeutics Market: Key Factors 7.4 Asia Pacific Epilepsy Therapeutics Market: Segment Analysis 7.5 Asia Pacific Epilepsy Therapeutics Market Segmentation: By Generation 7.5.1 Asia Pacific Epilepsy Therapeutics Market, By Generation Overview 7.5.2 Asia Pacific Epilepsy Therapeutics Market Size, By First Generation, By Value, 2020H-2030F (USD Million & CAGR) 7.5.3 Asia Pacific Epilepsy Therapeutics Market Size, By Second Generation, By Value, 2020H-2030F (USD Million & CAGR) 7.5.4 Asia Pacific Epilepsy Therapeutics Market Size, By Third Generation, By Value, 2020H-2030F (USD Million & CAGR) 7.6 Asia Pacific Epilepsy Therapeutics Market Segmentation: By Route of Administration 7.6.1 Asia Pacific Epilepsy Therapeutics Market, By Route of Administration Overview 7.6.2 Asia Pacific Epilepsy Therapeutics Market Size, By Oral, By Value, 2020H-2030F (USD Million & CAGR) 7.6.3 Asia Pacific Epilepsy Therapeutics Market Size, By Intravenous, By Value, 2020H-2030F (USD Million & CAGR) 7.7 Asia Pacific Epilepsy Therapeutics Market Segmentation: By Type 7.7.1 Asia Pacific Epilepsy Therapeutics Market, By Type Overview 7.7.2 Asia Pacific Epilepsy Therapeutics Market Size, By Branded, By Value, 2020H-2030F (USD Million & CAGR) 7.7.3 Asia Pacific Epilepsy Therapeutics Market Size, By Generics, By Value, 2020H-2030F (USD Million & CAGR) 7.8 Asia Pacific Epilepsy Therapeutics Market Segmentation: By Country 7.8.1 Asia Pacific Epilepsy Therapeutics Market, by Country Overview 7.8.2 China Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR) 7.8.2.1 China Epilepsy Therapeutics Market, By Generation 7.8.2.2 China Epilepsy Therapeutics Market, By Route of Administration 7.8.2.3 China Epilepsy Therapeutics Market, By Type 7.8.3 Japan Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR) 7.8.3.1 Japan Epilepsy Therapeutics Market, By Generation 7.8.3.2 Japan Epilepsy Therapeutics Market, By Route of Administration 7.8.3.3 Japan Epilepsy Therapeutics Market, By Type 7.8.4 India Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR) 7.8.4.1 India Epilepsy Therapeutics Market, By Generation 7.8.4.2 India Epilepsy Therapeutics Market, By Route of Administration 7.8.4.3 India Epilepsy Therapeutics Market, By Type 7.8.5 Rest of Asia Pacific Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR) 7.8.5.1 Rest of Asia Pacific Epilepsy Therapeutics Market, By Generation 7.8.5.2 Rest of Asia Pacific Epilepsy Therapeutics Market, By Route of Administration 7.8.5.3 Rest of Asia Pacific Epilepsy Therapeutics Market, By Type 8. Middle East and Africa Epilepsy Therapeutics Market: Historic and Forecast 8.1 Middle East and Africa Epilepsy Therapeutics Market: Snapshot 8.2 Middle East and Africa Epilepsy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR) 8.3 Middle East and Africa Epilepsy Therapeutics Market: Key Factors 8.4 Middle East and Africa Epilepsy Therapeutics Market: Segment Analysis 8.5 Middle East and Africa Epilepsy Therapeutics Market Segmentation: By Generation 8.5.1 Middle East and Africa Epilepsy Therapeutics Market, By Generation Overview 8.5.2 Middle East and Africa Epilepsy Therapeutics Market Size, By First Generation, By Value, 2020H-2030F (USD Million & CAGR) 8.5.3 Middle East and Africa Epilepsy Therapeutics Market Size, By Second Generation, By Value, 2020H-2030F (USD Million & CAGR) 8.5.4 Middle East and Africa Epilepsy Therapeutics Market Size, By Third Generation, By Value, 2020H-2030F (USD Million & CAGR) 8.6 Middle East and Africa Epilepsy Therapeutics Market Segmentation: By Route of Administration 8.6.1 Middle East and Africa Epilepsy Therapeutics Market, By Route of Administration Overview 8.6.2 Middle East and Africa Epilepsy Therapeutics Market Size, By Oral, By Value, 2020H-2030F (USD Million & CAGR) 8.6.3 Middle East and Africa Epilepsy Therapeutics Market Size, By Intravenous, By Value, 2020H-2030F (USD Million & CAGR) 8.7 Middle East and Africa Epilepsy Therapeutics Market Segmentation: By Type 8.7.1 Middle East and Africa Epilepsy Therapeutics Market, By Type Overview 8.7.2 Middle East and Africa Epilepsy Therapeutics Market Size, By Branded, By Value, 2020H-2030F (USD Million & CAGR) 8.7.3 Middle East and Africa Epilepsy Therapeutics Market Size, By Generics, By Value, 2020H-2030F (USD Million & CAGR) 9. Market Dynamics 9.1 Impact assessment of Market Dynamics on Epilepsy Therapeutics Market 9.2 Drivers 9.3 Restraints 9.4 Trends 10. Industry Ecosystem Analysis 10.1 Porter Analysis 11. Competitive Positioning 11.1 Companies’ Product Positioning 11.2 Market Position Matrix 11.3 Market Share Analysis of Epilepsy Therapeutics Market 11.4 Company Profiles 11.4.1 Novartis 11.4.2 Pfizer 11.4.3 GSK plc. 11.4.4 Merck & Co., Inc. 11.4.5 Johnson & Johnson 11.4.6 Sanofi 11.4.7 Teva Pharmaceuticals 11.4.8 Abbott Laboratories 11.4.9 Jazz Pharmaceuticals 11.4.10 Neurelis, Inc. 12. About Us & Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポート
Azoth Analytics社の 医療・製薬分野 での最新刊レポート
本レポートと同じKEY WORD(therapeutics)の最新刊レポート
よくあるご質問Azoth Analytics社はどのような調査会社ですか?調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|